| Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review AL Gillespie, R Samanaite, J Mill, A Egerton, JH MacCabe BMC psychiatry 17, 1-14, 2017 | 259 | 2017 |
| Self-reported rates of abuse, neglect, and bullying experienced by transgender and gender-nonbinary adolescents in China K Peng, X Zhu, A Gillespie, Y Wang, Y Gao, Y Xin, J Qi, JJ Ou, S Zhong, ... JAMA network open 2 (9), e1911058-e1911058, 2019 | 85 | 2019 |
| The efficacy of eye movement desensitization and reprocessing in children and adults who have experienced complex childhood trauma: A systematic review of randomized controlled … R Chen, A Gillespie, Y Zhao, Y Xi, Y Ren, L McLean Frontiers in psychology 9, 534, 2018 | 84 | 2018 |
| DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia E Hannon, EL Dempster, G Mansell, J Burrage, N Bass, MM Bohlken, ... Elife 10, e58430, 2021 | 80 | 2021 |
| Biological Predictors Of Clozapine Response: A Systematic Review R Samanaite*, A Gillespie*, KV Sendt, G McQueen, JH MacCabe, ... Frontiers in Psychiatry 9, 327, 2018 | 56 | 2018 |
| Health care and mental wellbeing in the transgender and gender-diverse Chinese population X Zhu, Y Gao, A Gillespie, Y Xin, J Qi, J Ou, S Zhong, K Peng, T Tan, ... The Lancet Diabetes & Endocrinology 7 (5), 339-341, 2019 | 49 | 2019 |
| Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia G McQueen, KV Sendt, A Gillespie, A Avila, J Lally, K Vallianatou, ... Schizophrenia Bulletin, 2021 | 44 | 2021 |
| Translating the promise of 5HT4 receptor agonists for the treatment of depression SE Murphy, AN De Cates, AL Gillespie, BR Godlewska, JC Scaife, ... Psychological medicine 51 (7), 1111-1120, 2021 | 33 | 2021 |
| Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study Y Liu, X Yang, A Gillespie, Z Guo, Y Ma, R Chen, Z Li Psychiatry research 272, 275-283, 2019 | 19 | 2019 |
| Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research MJ Colwell, H Tagomori, S Chapman, AL Gillespie, PJ Cowen, CJ Harmer, ... Translational Psychiatry 12 (1), 484, 2022 | 18 | 2022 |
| Effectiveness of mirtazapine as add-on to paroxetine v. paroxetine or mirtazapine monotherapy in patients with major depressive disorder with early non-response to paroxetine … L Xiao, X Zhu, A Gillespie, Y Feng, J Zhou, X Chen, Y Gao, X Wang, X Ma, ... Psychological Medicine 51 (7), 1166-1174, 2021 | 18 | 2021 |
| Mental health workers perceptions of disaster response in China Y Xi, R Chen, AL Gillespie, Y He, C Jia, K Shi, Y Yao, X Ma, W Liu, ... BMC public health 19, 1-13, 2019 | 15 | 2019 |
| Online behavioural activation during the COVID-19 pandemic decreases depression and negative affective bias T Ruzickova, J Carson, S Argabright, A Gillespie, C Guinea, A Pearse, ... Psychological medicine 53 (3), 795-804, 2023 | 7 | 2023 |
| Associations between statin use and negative affective bias during COVID-19: an observational, longitudinal UK study investigating depression vulnerability AL Gillespie, C Wigg, I Van Assche, SE Murphy, CJ Harmer Biological psychiatry 92 (7), 543-551, 2022 | 7 | 2022 |
| Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia F Krajner, L Hadaya, G McQueen, KV Sendt, A Gillespie, A Avila, J Lally, ... Schizophrenia 8 (1), 1-8, 2022 | 7 | 2022 |
| Applying the Higher Education Academy framework for partnership in learning and teaching in higher education to online partnership learning communities: a case atudy and an … E Kravariti, A Gillespie, K Diederen, SE Smart, C Mayberry, AJ Meehan, ... Teaching & Learning Inquiry: The ISSOTL Journal 6 (2), 143-164, 2018 | 6 | 2018 |
| Risk factors for depression vulnerability during the COVID-19 pandemic: findings from the Oxford COSIE (COVID-19, Social Isolation and Emotion) Study A Gillespie, J Carson, I Van Assche, S Murphy, C Harmer EUROPEAN NEUROPSYCHOPHARMACOLOGY 40, S417-S418, 2020 | 4 | 2020 |
| Changes in immunoglobulin levels during clozapine treatment in schizophrenia K Griffiths, MR Mellado, R Chung, J Lally, G McQueen, KV Sendt, ... Brain, Behavior, and Immunity 115, 223-228, 2024 | 3 | 2024 |
| Can you feel the burn? using neuroimaging to illuminate the mechanisms of mindfulness interventions for pain A Gillespie, CJ Harmer American Journal of Psychiatry 179 (10), 705-707, 2022 | 2 | 2022 |
| SU116. Longitudinal Epigenetic Analysis of Clozapine Use in Treatment-Resistant Schizophrenia A Gillespie, E Hannon, E Dempster, D Collier, A Egerton, J Mill, ... Schizophrenia Bulletin 43 (suppl_1), S203-S203, 2017 | 1 | 2017 |
James MacCabeProfessor of Epidemiology and Therapeutics in Psychosis, Institute of Psychiatry, Psychology andVerified email at kcl.ac.uk
